0.9603

3.25% 0.0302

Oncolytics Biotech Inc (ONCY)

Overview News Price History Why ONCY Down? Discussions Forecast Stock Split

Oncolytics Biotech Inc stock is traded at $0.9603, with a volume of 630.81K. It is up +3.25% in the last 24 hours and down -5.85% over the past month. Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Previous Close:

$0.9301

Open:

$0.9199

24h Volume:

630.81K

Relative Volume:

0.49

Market Cap:

$111.52M

Revenue:

Net Income/Loss:

$-20.65M

P/E Ratio:

-4.4213

EPS:

-0.2172

Net Cash Flow:

$-14.43M

1W Performance:

+6.58%

1M Performance:

-5.85%

6M Performance:

-32.37%

1Y Performance:

+83.75%

1-Day Range:

$0.9131

$0.9812

1-Week Range:

$0.78

$0.9812

52-Week Range:

$0.3258

$1.51

Oncolytics Biotech Inc Stock (ONCY) Company Profile

Name

Oncolytics Biotech Inc

Sector

Healthcare (1118)

Industry

Biotechnology (624)

Phone

(403) 670-7377

Address

804, 322 - 11 AVENUE SW, CALGARY, AB

Employee

Twitter

@oncolytics

Next Earnings Date

2026-04-03

Latest SEC Filings

ONCY's Discussions on Twitter

Compare ONCY vs VRTX, REGN, ARGX, ALNY, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ONCY Oncolytics Biotech Inc	0.9603	111.52M	0	-20.65M	-14.43M	-0.2172
VRTX Vertex Pharmaceuticals Inc	438.71	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	761.85	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	746.42	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	318.85	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	162.43	35.01B	606.42M	-1.28B	-997.58M	-6.403

Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-13-25	Initiated	Lake Street	Buy
Oct-06-22	Initiated	Maxim Group	Buy
Feb-17-21	Initiated	H.C. Wainwright	Buy

Oncolytics Biotech Inc Stock (ONCY) Latest News

01:39 AM

Oncolytics Biotech (NASDAQ:ONCY) Upgraded to Hold at Wall Street Zen - MarketBeat

01:39 AM

Apr 03, 2026

Oncolytics Biotech: Financial Data Forecasts Estimates and Expectations | ONYN | US68237V1035 - MarketScreener

Apr 03, 2026

Oncolytics Biotech’s U.S. Move Resets Regulatory Path And Valuation Debate - sahmcapital.com

Apr 03, 2026

Oncolytics Biotech: Target Price Consensus and Analysts Recommendations | ONCY | US68237V1035 - marketscreener.com

Apr 03, 2026

Oncolytics Biotech Inc.: Financial Data Forecasts Estimates and Expectations | ONCY | US68237V1035 - MarketScreener

Apr 03, 2026

Oncolytics Biotech: Revenue and Earnings Analysts Forecasts Revisions | ONCY | US68237V1035 - MarketScreener

Apr 03, 2026

Oncolytics Biotech Inc.: Fundamental Analysis and Financial Ratings | ONCY | US68237V1035 - MarketScreener

Apr 03, 2026

Apr 02, 2026

ONCY Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Apr 02, 2026